BML-111, a lipoxin receptor agonist, ameliorates ‘two-hit’-induced acute pancreatitis-associated lung injury in mice by the upregulation of heme oxygenase-1
Source abstract
Abstract
The objective of this study is to investigate the effects of BML-111 on acute pancreatitis-associated lung injury (APALI) induced by cerulein with subsequent an LPS administration in mice and its possible mechanisms. One hundred and twenty-eight mice were randomly allocated to four groups, namely the APALI group, the BML-111 pretreatment group, the BM-111 control group, and the control group. The 'two-hit' mice APALI model was established by intraperitoneal injection of cerulein 7 times at hourly intervals and Escherichia coli lipopolysaccharide (LPS) once after the last dose of cerulein immediately. The samples were taken at 3, 6, 12, and 24 h after the last injection. Serum levels of amylase, TNF-a, IL-1β and IL-10, were determined. Histological score of the pancreas and lung, the wet/dry weight ratio, and heme oxygenase-1 (HO-1) expression in the lung were also evaluated. BML-111 pretreatment significantly reduced the serum levels of amylase, TNF-α, IL-1β, the wet/dry weight ratio of lung, and the pathology injury scores of pancreas and lung, and the serum levels of IL-10 were markedly increased. The severity of pancreatic and lung histology were also significantly improved by the administration of BML-111, and the expressions of HO-1 in lung tissues also increased in the BML-111 group compared with those in the APALI group. In conclusion, BML-111 exerts protective effects on APALI induced by cerulein and LPS. In addition to its anti-inflammatory effects, the beneficial effects may also be due to the upregulation of HO-1 expression in the lung tissues.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Heme Oxygenase-1 and Carbon Monoxide · Pancreatitis Pathology and Treatment · Congenital Diaphragmatic Hernia Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (40)
Show source-provided references
1. Bae GS · World J Gastroenterol · 2012 · 18 · 3223
2. Barreto SG · World J Emerg Surg · 2007 · 2 · 3310.1186/1749-7922-2-33 ↗
3. Barreto SG · J Indian Med Assoc · 2008 · 106 · 575
4. Bogaard HJ · Circulation · 2009 · 120 · 195110.1161/CIRCULATIONAHA.109.883843 ↗
5. Chan KH · Clin Sci (Lond) · 2011 · 120 · 49310.1042/CS20100508 ↗
6. Chen Y · Mol Cancer Ther · 2010 · 9 · 216410.1158/1535-7163.MCT-10-0173 ↗
7. Chen YP · Hepatobiliary Pancreat Dis Int · 2009 · 8 · 535
8. Chiang N · Prostaglandins Leukot Essent Fatty Acids · 2005 · 73 · 16310.1016/j.plefa.2005.05.003 ↗
9. Conte FP · Br J Pharmacol · 2010 · 161 · 91110.1111/j.1476-5381.2010.00950.x ↗
10. Copple IM · Handb Exp Pharmacol · 2010 · 233
11. DiMagno MJ · Curr Opin Gastroenterol · 2007 · 23 · 494
12. Ding SP · World J Gastroenterol · 2003 · 9 · 58410.3748/wjg.v9.i3.584 ↗
13. 10.1016/j.resp.2009.06.00810.1016/j.resp.2009.06.008 ↗
14. Elder AS · Pancreatology · 2012 · 12 · 24010.1016/j.pan.2012.03.001 ↗
15. 10.1016/j.pan.2011.12.01210.1016/j.pan.2011.12.012 ↗
16. Gong J · Resuscitation · 2012 · 83 · 90710.1016/j.resuscitation.2011.12.035 ↗
17. Gong J · Med Hypotheses · 2012 · 79 · 9210.1016/j.mehy.2012.04.010 ↗
18. 10.1016/S1359-6101(03)00059-510.1016/S1359-6101(03)00059-5 ↗
19. Hao H · Cancer Lett · 2011 · 309 · 8510.1016/j.canlet.2011.05.020 ↗
20. Hofbauer B · Gastroenterology · 1998 · 115 · 123810.1016/S0016-5085(98)70096-4 ↗
21. Immenschuh S · Histol Histopathol · 2006 · 21 · 679
22. Jung KH · J Pineal Res · 2010 · 48 · 23910.1111/j.1600-079X.2010.00748.x ↗
23. Li M · Biol Pharm Bull · 2011 · 34 · 59510.1248/bpb.34.595 ↗
24. 10.1097/MPA.0b013e318224055210.1097/MPA.0b013e3182240552 ↗
25. Nakamichi I · J Clin Invest · 2005 · 115 · 300710.1172/JCI24912 ↗
26. Otterbein LE · Trends Immunol · 2003 · 24 · 44910.1016/S1471-4906(03)00181-9 ↗
27. Pastor CM · FASEB J · 2001 · 15 · 89310.1096/fj.00-0672rev ↗
28. Pastor CM · Chest · 2003 · 124 · 234110.1378/chest.124.6.2341 ↗
29. 10.2174/09298670677852201110.2174/092986706778522011 ↗
30. 10.1097/00000658-199201000-0000710.1097/00000658-199201000-00007 ↗
31. Seo SW · Int J Mol Med · 2011 · 27 · 53
32. Shen HN · Pancreas · 2011 · 40 · 1010.1097/MPA.0b013e3181f7e750 ↗
33. Steer ML · Respir Physiol · 2001 · 128 · 1310.1016/S0034-5687(01)00259-6 ↗
34. Wang M · Cell Death Differ · 2010 · 17 · 48810.1038/cdd.2009.144 ↗
35. Wang X · Pancreas · 2010 · 39 · 11410.1097/MPA.0b013e3181b65dd5 ↗
36. Weis S · PLOS ONE · 2012 · 7 · 3798110.1371/journal.pone.0037981 ↗
37. Yang R · J Surg Res · 2009 · 153 · 30210.1016/j.jss.2008.04.004 ↗
38. 10.1111/j.1872-034X.2007.00154.x10.1111/j.1872-034X.2007.00154.x ↗
39. Zhang L · Inflamm Res · 2008 · 57 · 15710.1007/s00011-007-7141-z ↗
40. Zhou M · Scand J Gastroenterol · 2011 · 46 · 21110.3109/00365521.2010.525715 ↗